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Abstract
We have studied infection of Cryptococcus neoformans in the non-vertebrate host Galleria mellonella with particular interest
in the morphological response of the yeast. Inoculation of C. neoformans in caterpillars induced a capsule-independent
increase in haemocyte density 2 h after infection. C. neoformans manifested a significant increase in capsule size after
inoculation into the caterpillar. The magnitude of capsule increase depended on the temperature, being more pronounced
at 37uC than at 30uC, which correlated with an increased virulence of the fungus and reduced phagocytosis at 37uC. Capsule
enlargement impaired phagocytosis by haemocytes. Incubation of the yeast in G. mellonella extracts also resulted in capsule
enlargement, with the polar lipidic fraction having a prominent role in this effect. During infection, the capsule decreased in
permeability. A low proportion of the cells (,5%) recovered from caterpillars measured more than 30 mm and were
considered giant cells. Giant cells recovered from mice were able to kill the caterpillars in a manner similar to regular cells
obtained from in vivo or grown in vitro, establishing their capacity to cause disease. Our results indicate that the
morphological transitions exhibited by C. neoformans in mammals also occur in a non-vertebrate host system. The
similarities in morphological transitions observed in different animal hosts and in their triggers are consistent with the
hypothesis that the cell body and capsular responses represent an adaptation of environmental survival strategies to
pathogenesis.
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Introduction
The yeast Cryptococcus neoformans is the causative agent of
cryptococcosis, a life-threatening fungal infection. C. neoformans
infectious particles, probably consisting of spores [1,2], are
believed to be acquired by inhalation. In immunocompetent hosts
the infection is often asymptomatic while in patients with impaired
immunity, and especially those with advanced HIV infection,
there is often extrapulmonary dissemination leading to meningo-
encephalitis [3,4]. Although the incidence of HIV-associated
cryptococcosis has declined in developed countries with the
introduction of the highly active anti-retroviral therapy, its
incidence in developing regions, such as sub-Saharan Africa
remains very high, causing more than 650.000 deaths per year [5].
C. neoformans often causes chronic infection in both humans and
animal hosts [3,6], but this stage of the infection is not well
understood. There is indirect evidence that the inability of the host
to clear the infection depends on the interaction with phagocytic
cells and on the polysaccharide capsule surrounding the
cryptococcal cells [7,8,9]. In this regard, capsular polysaccharides
are potent immunomodulators that interfere with immune
responses [10,11,12,13,14,15,16], and consequently the capsule
is considered the major virulence factor [17]. However, when C.
neoformans invades a host it also undergoes changes that contribute
to its persistence. These changes include capsule enlargement and
the appearance of giant cells [18,19,20]. C. neoformans can infect a
wide variety of hosts, such as the amoeba Acanthamoeba castellanii,
the nematode Caenorhabditis elegans, the slime mold Dictyostelium
discoideum, insects such as Drosophila melanogaster and the Lepidop-
tera Galleria mellonella [21,22,23,24,25,26]. Further extending its
host range, C. neoformans has been shown to infect plants [27].
Some of the alternative models mentioned above are limited by
the inability of the host system to survive at 37uC or the difficulty
in administering exact fungal inoculum. These limitations do not
apply to the Galleria mellonella model host. C. neoformans can
proliferate in the G. mellonella haemocoele leading to the eventual
death of the caterpillar [23]. Moreover, the G. mellonella model has
been used to study host defense to fungal pathogens [28].
Although C. neoformans morphological changes have been
described in yeast isolated from lungs of infected mice [18,29],
their role during infection is not completely understood. The use of
an alternative host, such as G. mellonella, provides a new system to
investigate the importance of specific traits on virulence that has
significant advantages over other hosts. We have investigated the
interaction between C. neoformans and G. mellonella and report that
cryptococcal infection in this host is also associated with significant
morphological changes, such as capsule enlargement and the
appearance of giant cells, which play an important role in evading
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occur in vertebrates, our observations indicate similar cellular
responses by C. neoformans in very different types of hosts.
Results
Administration of C. neoformans produces a transient
increase in haemocyte density
To characterize the interaction between G. mellonella and C.
neoformans, we first reproduced the model infection and investigated
aspects of the insect immune response during infection with this
fungal pathogen. For this purpose, we inoculated larvae with
different dosesfrom H99strain,and observed that the larvae died in
a dose dependant manner (data not shown). Galleria mellonella
induces innate responses, some of them based on the increase in the
concentration of haemocytes in the haemolymph at different times
[30,31]. Consequently, we enumerated the number of haemocytes
present in the haemolymph at different times, and we observed that
larvae injected with 10
4 C. neoformans cells showed a 7-fold increase
in the number of haemocytes after 2 h of infection (p,0.05).
However, this response was not maintained during subsequent days
(Figure 1A). Furthermore, we also tested a capsule-deficient strain of
C. neoformans and its parental strain (cap59 and B3501, respectively)
and we did not observe any statistical differences in the haemocyte
density of the larvae infected with these strains (p=0.5) (Figure 1B)
indicating that this response is capsule-independent. Heat-killed C.
neoformans cells were also inoculated in larvae and no increase in
haemocyte density was observed (result not shown).
C. neoformans morphogenesis during infection in G.
mellonella
Since C. neoformans manifests morphological transitions during
mammalian infection involving changes in the capsule and total
size, we investigated whether similar changes occurred during G.
mellonella infection. Hence, we measured the total cell diameter
(capsule included), cell body size (delimited by the cell wall) and
capsule diameter of yeast cells recovered from larvae incubated at
37uC at various times of infection. The size of cells grown in
Sabouraud overnight used to infect the larvae was considered time
zero for infection. C. neoformans cells manifested a significant
increase in average cell size during infection in G. mellonella at all
times tested (Figure 2). This increase was due to both an increase
in the cell body size and in the size of the capsule when comparing
to cells in vitro (p,0.05, Figure 2).
Effect of capsule enlargement on phagocytosis
We then investigated if cryptococcal morphogenesis played a
role in virulence in G. mellonella. Since initial infection of the larvae
was associated with a strong recruitment of haemocytes in the
haemolymph, we investigated the importance of capsule growth
on haemocyte and phagocytosis. For this purpose, we induced
capsule enlargement in vitro by incubating the cells in diluted
Sabouraud liquid medium at neutral pH (see Material and
Methods). When the larvae were infected with cells incubated in
Sabouraud broth, we observed that approximately 20% of the
haemocytes contained C. neoformans cells after 2 h of incubation
(Figure 3A). In contrast, capsule enlargement completely inhibited
phagocytosis (Figure 3A). However, when we compared the
survival of the larvae infected with C. neoformans cells with either
small or large capsules, we did not observe a difference in virulence
(Figure 3B), indicating that initial phagocytosis did not predict the
course of infection. To confirm that the capsule had an inhibitory
role of phagocytosis by haemocytes, we infected larvae with
encapsulated (H99 and B3501) and the cap59 mutant (C536
strain). Phagocytosis percentage increased to around 30% when
using the capsule-deficient strain (Figure 3C, p,0.05). No
differences in phagocytosis were observed when using encapsulat-
ed C. neoformans var. grubii H99 or C. neoformans var. neoformans
B3501 cells (Figure 3C).
Temperature dependent morphogenesis of C.
neoformans in G. mellonella
The virulence of C. neoformans in G. mellonella was reported to be
decreased at 30uC compared to physiological mammalian
temperature [23]. Consequently, we investigated whether this
difference in virulence correlated with differences in morphogen-
esis. We first reproduced the temperature-dependent virulence
phenotype, and as shown in Figure 4A, we confirmed that
virulence of C. neoformans was enhanced at 37uC. We wanted to
rule out that the enhanced virulence at 37uC was due to a better
growth of the yeast at this temperature, so we performed growth
curves at 30 and 37uC. We found that the growth rate was higher
at 30uC than at 37uC (Figure 4B). In addition, we studied whether
phagocytosis of C. neoformans was affected by the incubation
temperature. To this end, we performed in vivo phagocytosis assays
at both temperatures (Figure 4C). Two groups of larvae were
inoculated with 10
6 cells of C. neoformans previously stained with
Calcofluor White and incubated at both temperatures. After 2 h,
haemolymph was obtained from 3 different larvae in every group
to quantify phagocytosis. We observed that phagocytosis occurred
more efficiently at 30uC than at 37uC( p=0.0011). This data
suggests that the immune system of the larvae is impaired at 37uC.
However, and as shown in Figure 3, the initial phagocytosis does
not correlate with the outcome of the infection, so we investigated
the magnitude of morphological changes at 30 and 37uC. C.
neoformans exhibited a significant increase in the size of both the cell
body and the capsule during infection in G. mellonella at both
temperatures (Figure 4D). However, this increase was statistically
higher in cells from larvae at 37uC than from those kept at 30uC
(p,0.05) (Figure 4D).
Capsular rearrangements during infection in G. mellonella
We investigated if during G. mellonella infection, the capsule
underwent changes not only in size, but also in structure. So we
stained the capsule with mAb 18B7 conjugated to Alexa-488 and
compared the immunofluorescence pattern of cells grown in vitro and
cells recovered from caterpillars.In all cases, we found a clear annular
binding pattern of the Ab to the yeast cells (Figure 5A). However, for
cells recovered from G. mellonella, the mAb bound primarily to the
outer regions of the capsule and there was little or no fluorescence
signal from the regions close to the cell wall (Figure 5A), which
suggested that infection in G. mellonella w a sa s so ci a t e dw i t ha nin c re a se
in capsule density that reduced penetrability to the inner capsule. To
confirm this idea, we investigated the penetration of 70 kDa
fluorescent dextrans into the capsule. In cells grown in vitro,t h e
dextran penetrated in the capsule to regions close to the cell wall,
yielding a penetration to approximately 75% of the capsule diameter
(Figure 5B, 5C). However, in cells isolated from G. mellonella,t h e
dextran could not penetrate to the regions close to the cell wall
(Figure 5B,C; penetration index around 45%), implying a reduction
in permeability consistent with an increase in capsule density during
infection in the insect.
Capsular enlargement in vitro
In addition to the in vivo experiments, we also performed in vitro
experiments to study if C. neoformans induced capsule growth in the
presence of specific caterpillar factors. In addition to a whole
Cryptococcal Morphogenesis in Galleria mellonella
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24485caterpillar extract, we also investigated a polar lipidic fraction, since
similar fractions obtained from Acanthamoeba castellanii and murine
macrophages can induce capsule growth [32]. Sabouraud liquid
medium, PBS and 10% Sabouraud in 50 mM MOPS buffer pH 7.3
were also tested. We first analysed the growth of C. neoformans in each
ofthedifferent fractions.Growth curvesduring the first 72 hrevealed
very similar C. neoformans growth in diluted Sabouraud medium
(pH 7.3), complete G. mellonella extract and in the polar lipid rich
fraction (Figure 6A). No growth was observed in PBS (Figure 6A).
When we analyzed the size of the cells after 10 d, we observed that
incubation of C. neoformans in complete G. mellonella extract and in the
polar lipid extract resulted in cell size enlargement, due to both cell
body and capsule increase, compared to the same cells incubated in
Sabouraud broth (Figure 6B) or in PBS in which cells showed a
reduced size. In addition, the increase in capsule percentage obtained
when C. neoformans was incubated in the polar fraction was similar to
that observed in the capsule inducing medium (10% Sabouraud at
neutral pH, see Figure 6B).
C. neoformans forms giant cells during infection
In addition to capsule enlargement, another significant
morphological change associated with cryptococcal infection in
Figure 1. Haemocyte density in larvae after C. neoformans injection. A) Ten larvae were inoculated with 10
4 cells from H99 strain and
haemocyte densities were assessed at different times (2 h, 2 d and 5 d). Black bars show haemocyte density of larvae injected with PBS and white
bars of larvae injected with C. neoformans. B) Ten larvae per group were inoculated with 10
4 cells from H99, B3501 and the cap59 mutant (C536) and
haemocyte densities were assessed after 2 h after inoculation as described in Material and Methods. In both A and B, significant differences (p,0.05)
in haemocyte density relative to that in the PBS treated larvae are indicated with an asterisk. Experiments were repeated 3 times.
doi:10.1371/journal.pone.0024485.g001
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[19,20]. In our G. mellonella model less than 5% of the cells
recovered from day 6 infected larvae reached over 30 mm and thus
could be considered giant cells (Figure 7A). However, cells with a
diameter between 20–30 mm could be observed after 4 days in
larvae infected with 10
4 yeast cells. This phenomenon was also
observed in caterpillars infected with 10
2 and 10
3 inocula, but only
after 6 days of infection (data not shown). We observed that giant
cell formation involved a 75-fold increase in cellular volume
relative to cells grown in Sabouraud liquid medium. The giant size
of these cells was achieved not only by capsule enlargement, but
also by an increase of the cell body size (Figure 7A).
Chitin-like structures in the capsule were reported by the
specific binding of fluorescent wheat germ agglutinin, which binds
to sialic acids and b-1,4-N-acetylglucosamine (GlcNAc) oligomers
[33]. We used WGA to ascertain whether these structures were
also present in giant cells recovered from G. mellonella. Cells grown
in vitro bound WGA especially at the neck between the mother cell
and the bud (Figure 7B). In cells recovered from caterpillars, these
structures were particularly prominent (Figure 7B).
Giant cells virulence in G. mellonella model host
We used the G. mellonella model to investigate the virulence of
giant cells formed in mice. For this purpose, we isolated giant cells
from lungs of 3 week-infected mice. To separate giant from regular
cells in the lung extract, we filtered the yeast suspension through
20 mm pore size filters, which have been shown to retain most of
the giant cells [20]. As a control, we also used the cells that passed
through the filter (of which the majority were of regular size) and
cells grown in Sabouraud liquid medium overnight. We found that
giant cells had the same virulence capacity as cells of regular size
obtained from in vitro or in vivo (Figure 8A). To investigate whether
the size of the giant cells was maintained during infection, fungal
cells were recovered from larvae from every group at different
times and their sizes measured. An increase in total cell size
(capsule included) was found in cells recovered from larvae
infected with cells grown in vitro and in those infected with C.
neoformans with a cell size below 20 mm isolated from mouse lungs
(Figure 8B). In contrast, in larvae infected with giant cells, the cells
recovered after 2 d from the caterpillars had a decreased size, and
giant cells were hardly found (Figure 8B). Nevertheless, after 5 d of
infection cells isolated from larvae seemed to begin to increase
their size again and they showed an average size of 26 mm
(Figure 8B).
Discussion
Virulence of human pathogens has classically been studied in
mammalian models, with mice being the most widely used species.
In recent years there has been increasing interest in the use of
other model hosts, given concerns about the expense and
bioethical issues involved in vertebrate animal experimentation.
However, the use of these alternative models must be validated
before the results obtained can be extrapolated to more complex
models, such as the mouse. In this sense, it is important to establish
whether the interaction between non-vertebrate model hosts and
Figure 2. Morphogenesis of C. neoformans during infection in G.
mellonella. Distribution of total cell size, cell body size and capsule
diameter of C. neoformans cells grown in Sabouraud (T=0) and
recovered from G. mellonella caterpillars at different times after
inoculation of 10
4 yeast cells. Total cell size was defined as the diameter
of the complete cell including the capsule. The capsule diameter was
calculated asthedifferencebetweenthe wholecellsizeandthecell body
size. T-test and scatter plot graphs were obtained using Graph Pad Prism
5. The bar denotes the average of the distribution. Asteriks indicate
p,0.05.
doi:10.1371/journal.pone.0024485.g002
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conventional types of hosts. Galleria mellonella caterpillars have been
used for the study of pathogenesis with such different pathogens as
Pseudomonas aeruginosa, Proteus mirabilis and Escherichia coli
[34,35,36,37,38]. Among human fungal pathogens, Candida
albicans and some Aspergillus spp, such as A. fumigatus and A. flavus,
also kill caterpillars [28,31,39,40]. The immune response elicited
by G. mellonella during C. neoformans infection is very different from
that elicited in mammalian cells. As invertebrates, insects lack
adaptive immune responses and do not produce immunoglobulins.
However, insects have powerful innate immune mechanisms that
include the presence of haemocytes with phagocytic activity
[41,42,43,44], which in some aspects resemble the activity of
macrophages and neutrophils from the innate immune system of
mammalian organisms. In addition, another part of the innate
immune response in insects depends on the role of reactions
catalyzed by a phenoloxidase that enable to encase pathogens in
melanin [45]. C. neoformans induced a 7-fold increase in haemocyte
density in caterpillars during the first 2 h of infection. This acute
response was capsule and strain independent and not maintained
in time, but required living cells. Hence, C. neoformans in mammals
and insects is likely to encounter different challenges for survival.
Consequently, the question of how C. neoformans responds in the
setting of mammalian and insect infection is relevant for our
understanding of pathogenesis and the origin of virulence of this
fungus.
Morphological changes have been described in mouse models
during the infection in the lungs. These morphological changes
include capsule enlargement and the formation of giant cells,
which could be important for the persistence of the yeasts in the
host. We have confirmed that similar changes occur during
infection in G. mellonella, which supports the idea that this model
can be used to study morphological aspects of C. neoformans
infection, which might be then extrapolated to mouse models. In
addition, G. mellonella offered a simple model to study the
importance of morphogenesis in virulence. In this sense, we found
that capsule enlargement inhibited phagocytosis. The mechanism
by which capsule growth impairs phagocytosis by haemocytes is
unknown, but a similar situation is observed with complement-
mediated phagocytosis of C. neoformans by murine macrophages
[46]. But it cannot be discarded that capsule growth inhibits
phagocytosis by producing cells of larger size which cannot be
ingested by haemocytes. However, the initial size of the capsule
did not influence virulence of the strain, most probably due to the
fact that during infection, cells with small capsule manifest
capsular enlargement, and consequently, become similar to those
incubated in capsule inducing medium. Moreover, our findings
suggest that the initial phagocytosis does not correlate with the
subsequent development of the disease, so the consequences of the
increase in haemocyte density and the exact role of phagocytosis in
protection against cryptococcal infections deserve future study. In
agreement with the antiphagocytic role of the capsule, we
observed that phagocytosis was increased when we used a
capsule-deficient strain, a situation with strong resemblance to
the observation that acapsular strains are readily ingested by
mammalian macrophages [47,48]. The capsule completely inhibits
phagocytosis, and in the case of mammalian macrophages,
phagocytosis of regular encapsulated C. neoformans strains com-
pletely depends on the presence of opsonins, such as complement
or antibodies (see review in [9]), and for this reason, few hours
Figure 3. Role of the capsule on phagocytosis by haemocytes.
A) Cells with small (grown in Sabouraud) and large capsule (incubated
in 10% Sabouraud buffered with 50 mM MOPS pH 7.3) were stained
with Calcofluor and used to infect caterpillars. Bars show the average
phagocytosis at 2 h. p,0.05 is indicated with an asterisk. The
experiment was repeated twice in triplicates. B) Survival curves of G.
mellonella infected with 10
4 cells of C. neoformans grown in Sabouraud
broth and in 10% Sabouraud diluted in MOPS pH 7.3. C) In vivo
phagocytosis using H99, B3501 and cap59 (C356) strains was performed
as described in section A and quantified after 2 h of infection. Bars
show phagocytosis average after 2 h. P value below 0.05 is indicated
with an asterisk.
doi:10.1371/journal.pone.0024485.g003
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inside phagocytic cells [49]. In G. mellonella, we found that around
20% of haemocytes contained C. neoformans cells after 2 h of
infection, and we believe that this phagocytosis is also produced by
insect opsonins.
We noted another instance where capsule and cell enlargement
correlated with virulence, which is the different virulence shown
by C. neoformans at different temperatures [23]. This difference was
not explained by a better growth of the yeast at high temperature,
but correlated with decreased phagocytosis and a larger capsule,
which we believe translates into phagocytic avoidance. This data is
also in agreement with previous findings that demonstrated that
capsule enlargement in vitro was enhanced at physiological
temperature [50]. In addition to this enhanced fungal response,
the immunity of the larvae seems to be diminished at 37uC, as
shown by the reduced phagocytosis measured at this temperature.
Capsular enlargement in G. mellonella was associated with a
decrease in the permeability of the capsule, a phenomenon that
might have also important consequences for the recognition of the
pathogen by the host. Increases in capsule density can affect
penetration of antifungal molecules and the binding of opsonins on
the capsule. Capsular rearrangement in the C. neoformans capsule
was described both during infection [51,52] and in vitro [50,53,54],
and this phenomenon has been associated with cellular aging [53].
Our findings highlight that this particular ability of C. neoformans to
modulate capsular structural features might have important
consequences for multiple types of interactions, with both the
environment and the host.
The molecular mechanisms that allow capsule enlargement are
unknown. A common feature of capsule growth is that it occurs in
poor nutritional conditions, where normally the growth rate of the
yeast is impaired, so it is possible that one parameter that
Figure 4. Temperature dependent virulence and morphogenesis of C. neoformans in G. mellonella.A ) Survival curves of G. mellonella
infected with 10
4 H99 cells. Sixteen larvae per group were incubated at 30uC( .) and 37uC( m). A group of larvae were injected with PBS and kept at
30uC(N) and at 37uC( &) to control the trauma of the injection. B) Growth curves of H99 strain at 30uC (Black line) and at 37uC (grey dotted line)
during 48 h. C) In vivo phagocytosis was performed as described in Material and Methods and quantified after 2 h of incubation of the larvae at 30uC
and 37uC. P,0.05 is indicated with an asterisk. D) Distribution of total cell size, cell body size and capsule diameter of C. neoformans cells grown in
Sabouraud (Sab) and recovered from G. mellonella caterpillars at different temperatures after 6 d of infection. T-test and scatter plot graphs were
performed using Graph Pad Prism 5. The line in each sample denotes the average of the distribution.
doi:10.1371/journal.pone.0024485.g004
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Although this concept might be true, we believe that capsule
enlargement is also induced by host specific factors. We were able
to induce capsule enlargement by incubating cryptococcal cells
with caterpillar extracts, and in particular, with the polar lipidic
fraction, which is in agreement with recent findings of C. neoformans
using extracts from Acanthamoeba castellanii and macrophages [32].
In these conditions, growth rate was compromised, so we argue
that decreased growth in required to induce capsule enlargement
in the presence of specific inducers, such as host lipids.
Conservation of this effect in insects supports the view that
phospholipid sensing might be a general response that is
stimulated by common elements present in different hosts.
The formation of C. neoformans giant cells could pose a major
problem to the immune system simply by virtue of their size [19,20].
In this work, we isolated giant cells from caterpillars after 6 d of
infection at 37uC. Furthermore, in the G. mellonella model, cells of 20–
30 mm couldbe observed by 4 d post-infection in larvae infected with
10
4 inoculum, and at day 6 in larvae infected with 10
2 and 10
3 cells.
Consequently, we surmise that infection with 10
2 or 10
3 was better
controlled by caterpillar haemocytes. Giant cells isolated from G.
mellonella manifested several similarities with the giant cells isolated
from mice, such as the presence of chitin-like structures which might
be involved in the movement of the bud through the capsule of the
mother cell [33]. However, we also noticed structural differences
between giant cells obtained from G. mellonella and mice. Giant cells
from mice were consistently larger than those obtained from the
insect, and had prominently enlarged cell walls [20]. Although it is
possible that giant cells formed in insects and in mammals are
different, we believe that the most likely explanation for the
differences observed is the time of infection. In mice, we routinely
recover the giant cells after 3 weeks of infection, so the yeasts have
more time to become larger and develop specific structural features
than in the insect model, since they are obtained only after 6 d of
infection due to short lifespan of infected caterpillars. This makes very
difficult to obtain giant cells from infected insects for a longer time. In
addition, giant cells from mice were polyploid [19,20], which suggests
a mechanism of giant cell formation by endoreduplication. In the case
of giant cells obtained from G. mellonella, this aspect could not be
studied due to the relatively scarce number of giant cells recovered
from the larvae, which precluded the use of specific techniques, such
asDNA staining and analysisby flowcytometry, tomeasure the DNA
content. Despite thesedifferences, our resultsindicate thatG. mellonella
offers a simple system to study the early stages of giant cell formation
and could be used as a rapid and inexpensive model to screen for
mutants affected in this process.
In addition, G. mellonella can be used to study specific aspects of
cryptococcal virulence. For example, we observed that giant cells
isolated from mice can kill the caterpillars in a very similar way to
cells of regular size, obtained from both in vivo and in vitro.
Furthermore, 2 d after infection with giant cells, most of the cells
recovered from larvae were not giants, indicating that giant cells in
vivo produced smaller cells, as we observed in vitro [20]. Since giant
cells have been shown to be more resistant to some stress factors
[20], the observation that giant cells can produce infection
provides support for the notion that such cells could contribute
to latency and reactivation by virtue of their relatively invulner-
ability to host defense mechanisms, since they are too large to be
ingested [19,20]. In this regard, we hypothesize that giant cells
could linger in the lung and provide a source of infection with the
daughter cells being capable of extrapulmonary dissemination,
when hosts become immunosuppressed.
C. neoformans factors involved in mammalian pathogenesis are
also involved in the survival of C. neoformans within non
mammalian hosts [23,55,56]. In this work, we have shown that
G. mellonella provides a useful model to study morphological
cellular and capsular changes previously detected in mammal host.
Moreover, the ability to recover giant cells from caterpillars could
Figure 5. Capsular permeability of C. neoformans cells isolated
from G. mellonella.A ) Immunofluorescence staining of the capsule
with mAb18B7-Alexa 488 (green fluorescence) and of the cell body
(blue fluorescence) of cryptococcal cells grown in Sabouraud broth and
recovered from caterpillars infected with 10
4 cells per larva after 6 d.
Scale bar in left panel applies to both. B) Penetration of 70 KDa dextran
Rhodamine labeled into the capsule and estimation of total capsule size
by India ink staining. Upper panel shows cells grown in Sabouraud
broth and lower panel cryptococcal cells recovered after 6 d from
caterpillars infected with 10
4 cells per larva. Scale bar in left panel
applies to both. C) Distribution of permeability index calculated for cells
grown in Sabouraud liquid medium (Sabouraud) and for cells recovered
from infected larva (Galleria). T-test p value=0.0006.
doi:10.1371/journal.pone.0024485.g005
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using G. mellonella as it constitutes an inexpensive non-vertebrate
animal host. Our results also contribute to the understanding of
the origin of cryptococcal virulence since they imply the existence
of similar survival strategies in mammalian and insect hosts despite
major differences in the immune response of these animals.
Consequently, these observations support the notion that the
pathogenic potential of C. neoformans for animal hosts is a
consequence of selection pressures in the environment that
resulted in attributes also suitable for animal virulence [26,57].
Materials and Methods
Strains and media
The Cryptococcus neoformans var. grubii H99 strain, also known as
ATCC 20882 [58,59], was used throughout the study. C. neoformans
var. neoformans B5301 strain [60] and the capsule-deficient strain
C536 (which has a deletion in the CAP59 gene, [61]) were also used
in some experiments. C. neoformans cultures were grown in liquid
Sabouraud medium at 30uC with moderate shaking (150 r.p.m). To
induce capsule enlargement, the cells were incubated in 10%
Sabouraud buffered at pH 7.3 with 50 mM MOPS [62].
Galleria mellonella survival experiments
The Galleria mellonella larvae (Vanderhorst Wholesale, Inc, St
Marys, OH and Mous Livebait R.J., The Netherlands) used for
experiments were selected to be similar in size and absent of any
grey markings for reproducible results.
The selected larvae were inoculated with 10 mL of a yeast
suspension prepared at different cell densities by an injection in the
last left pro-leg using a 26 gauge needle with Hamilton syringes.
The syringes were prepared prior to the experiment by cleaning
them with bleach and ethanol. Before injection, the pro-leg area
was cleaned with 70% ethanol using a swab. After injection,
caterpillars were incubated in 90 mm plastic Petri dishes (Soria
genlab, S.A., Madrid, Spain) at 37uCo ra t3 0 uC, and the number
of dead caterpillars was scored daily. A group of caterpillars was
inoculated with PBS in each experiment to monitor killing due to
physical injury and another group of caterpillars without any
manipulation was carried out in parallel as an untreated control.
Killing curves were plotted and estimation of differences in
survival was analyzed by the Kaplan-Meier method using Graph
Pad Prism 5 (La Jolla, CA, USA). Every experiment was repeated
at least twice, obtaining always similar results. Data presented here
are from a representative experiment.
Isolation of C. neoformans cells from G. mellonella
To isolate the yeasts from G. mellonella, larvae were smashed
using cell strainers of 100 mm pore size (BD Falcon, Erembo-
Figure 6. In vitro capsule and cellular enlargement of C.
neoformans in G. mellonella extracts. Larvae were homogenized
and different extracts were prepared as described in Material and
Methods. A) Growth curves in Sabouraud (m), 10% Sabouraud diluted
in 50 mM MOPS pH 7.3 (N), total G. mellonella extract (x), Upper phase
of G. mellonella extract, containing polar lipids (¤) and PBS (*) at 37uC
during 3 d. B) Distribution of total cell size, cell body size and capsular
diameter of C. neoformans cells in Sabouraud (Sab), Sabouraud buffered
with MOPS (10%Sab pH 7.3), G. mellonella extract (Gal), upper phase of
G. mellonella lipid extraction (Upper phase) and PBS at 37uC for 10 d. T-
test comparing cells in different media to cells grown in Sabouraud
broth and scatter plot graphs were done using Graph Pad Prism 5. The
line in each sample denotes the average of the distribution. P,0.05 is
indicated with an asterisk.
doi:10.1371/journal.pone.0024485.g006
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Madrid, Spain). Homogenates were collected in 1 mL of PBS and
samples were washed twice and suspended in 150 mL of PBS.
Fungal cells were suspended in India ink (Remel Bactidrop,
Lenexa, KS, USA), observed by microscopy and photographed.
Photographs were taken using a Leica DMI 3000B microscope in
all experimental work. In parallel, cryptococcal cells grown
overnight in Sabouraud broth were observed by microscopy,
photographed and used to infect the larvae.
Cell and capsule sizes were measured using Adobe Photoshop
7.0 (San Jose, CA). Total cell size was defined as the diameter of
the complete cell including the capsule. Capsule size was
calculated as the difference between the diameter of the total cell
and the cell body diameter, defined by the cell wall. T-test and
scatter plot graphs were done using Graph Pad Prism 5 (La Jolla,
CA, USA). A P value,0.05 was considered significant.
G. mellonella extract preparation and lipid extraction
Twenty to thirty larvae were smashed in PBS and the
homogenate was collected and centrifuged at 3000 r.p.m. for
5 min. Total extracts were obtained after filtering the supernatant
through 0.22 mm pore size filters (Millex, Co. Cork, Ireland). To
obtain polar lipidic fractions, we followed the protocol described in
[32]. Briefly, the total extract was incubated with a mixture of
chloroform and methanol (2:1, v:v) for 3 h on a benchtop rocker at
room temperature. The samples were then centrifuged for 10 min
at 2500 r.p.m for phase partitioning. The upper phase was
collected and dried overnight in a vacuum centrifuge. The pellet
was finally suspended in PBS.
Capsular enlargement assay upon fractionation
Total G. mellonella extract and the lipidic fraction were tested for
capsule enlargement with C. neoformans strain H99. Sabouraud
liquid medium, diluted Sabouraud (10%) in 50 mM MOPS
pH 7.3, and PBS were also tested in parallel. A ninety six-well
plate was used to incubate 10
4 cells per well in triplicates with the
different media at 37uC with shaking for 10 d. Capsular size was
measured as described above.
Immunofluorescent staining of the capsule
Suspensions of C. neoformans recovered from caterpillars after 6 d
of infection and C. neoformans grown in Sabouraud broth overnight
at 30uC were stained with mAb18B7 [63] conjugated to Alexa 488
at a final concentration of 10 mg/mL for 30 min at 37uC in the
dark. Samples were washed 3 times with PBS and incubated with
0.1% Uvitex for 15 min at room temperature in dark. Samples
were then washed 4 times and the pellets were suspended in 0.1 M
n-propyl-gallate (Sigma, St. Louis, MO, USA) in PBS. Photo-
graphs were taken using an Olympus IX70 microscope (Olympus
America, Melville, NY).
Wheat germ agglutinin staining
To evaluate the presence of chitin-like structures, fungal cells
grown in Sabouraud liquid medium at 30uC overnight and cells
recovered from G. mellonella larvae 6 d post-infection were stained
with wheat germ agglutinin (WGA) as reported previously [33].
Briefly, the cells were washed with PBS, suspended in 4% p-
formaldehyde cacodylate buffer (0.1 M, pH 7.2) and incubated for
30 min at room temperature. The fixed cells were then washed
with PBS and suspended in 100 mLo f5mg/mL WGA conjugated
to Alexa 594 (Molecular Probes, Invitrogen) for 1 h at 37uC. Cell
suspensions were mounted on glass slides and photographed with a
Leica DMI 3000B fluorescence microscope.
Capsule penetrability assay
Capsule penetrability assays were performed as described in
[52] to define the porosity of the capsule to macromolecules.
Briefly, suspensions of C. neoformans recovered from caterpillars 6 d
after infection and C. neoformans grown in Sabouraud broth
overnight at 30uC were suspended in a mixture of India ink and
3.6 mg/mL of 70 KDa Rhodamine fluorescent dextrans (Sigma).
Samples were taken from those suspensions and photographs were
taken in bright field and in Rhodamine filter. Total cell size and
cell body size were measured in India ink suspensions as described
above. The area of the capsule where the dextran did not
penetrate was also measured by Rhodamine. The penetrability
index was calculated as follows: Total capsule size was estimated
after suspension in India ink, and the penetration of Rhodamine
labeled dextran was measured in parallel by subtracting the
diameter not penetrated by the fluorescent dextran from the total
cell body. The permeability index was defined with these two
values as the percentage of the capsule that was penetrated by the
fluorescent dextran referred to the total size of the capsule. Cells
Figure 7. Cryptococcus neoformans forms giant cells in Galleria
mellonella.A ) Figure shows photographs of C. neoformans cells
suspended in India ink after overnight growth in Sabouraud broth and
giant cells recovered from G. mellonella after 6 d of infection. Scale bar
applies to both panels. B) Binding of wheat germ agglutinin to C.
neoformans as described in Material and Methods. Upper panels show
cells grown in Sabouraud browth and lower panels show a
representative cell recovered from caterpillars after 6 d of infection.
doi:10.1371/journal.pone.0024485.g007
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statistics and graphs were obtained using Graph Pad Prism 5 as
explained previously.
C. neoformans growing curves in Sabouraud liquid
medium at 30uC and 37uC
C. neoformans strain H99 was grown overnight at 37uC with
moderate shaking. Suspensions of C. neoformans at 10
5/mL and
10
3/mL were prepared in Sabouraud and 200 mL were inoculated
in a 96-well plate (Costar, NY, USA) and incubated for 48 h with
moderate shaking every 30 min in an iEMS Spectrophotometer
(Thermofisher). Optical density at 540 nm was measured every
hour and graphs were plotted using Graph Pad Prism 5. The
growth curves were performed at both 30uC and at 37uCi n
different days in triplicates.
In vivo phagocytosis assays
C. neoformans was grown in liquid Sabouraud medium as
described above and stained with Calcofluor White (Sigma
Aldrich, St. Louis, Mo, USA) at 10 mg/mL for 30 min at 37uC.
In some experiments, yeast cells with enlarged capsules induced by
an overnight incubation in 10% Sabouraud buffered at pH 7.3
with 50 mM MOPS were used. After incubation, cells were
washed twice with PBS and suspended at 10
8 cells/mL. Larvae
were infected with 10 mL of the inoculum (10
6 cells) and incubated
at 37uC. In some experiments, a group of infected larvae was
incubated also at 30uC. After 2 h, haemolymph was obtained from
the caterpillars by insertion of a lancet into the haemocoele.
Haemolymph was collected in eppendorf tubes containing an
equal amount of an anticoagulant and antimelanization buffer IPS
(Insect Physiological Saline:150 mM sodium chloride, 5 mM
potassium chloride, 10 mM Tris-HCl pH 6.9, 10 mM EDTA
and 30 mM sodium citrate) and were centrifuged at 1500 r.p.m for
5 min to separate the haemocytes from the humoral fraction.
Pelleted haemocytes were washed twice with the same buffer and
the haemocytes were placed on coverslips and allowed to adhere
for 40 min. Coverslips were placed on the slides with Fluoromount
G and pictures were taken to quantify the phagocytosis with a
Leica DMI 3000B fluorescent microscope. Experiments were
performed in different days in triplicates. T-test (Microsoft Excel)
was used to analyze the data and a p value,0.05 was considered
significant.
Determination of haemocyte density
Larvae were inoculated with 10 mLo fa1 0
6/mL suspension of
either H99, B3501, C536 strains. In some experiments, C.
Figure 8. Survival of G. mellonella infected with giant cells isolated from mice. A) Balb/c mice were infected with H99 strain, and after 17 d,
yeast cells recovered from the lungs were separated according to their size. Two different samples were obtained: cells smaller than 20 mm or cells
larger than this size. Yeast cells incubated overnight in Sabouraud were carried out in parallel. Twenty larvae per group were inoculated with 10 mLo f
3610
5/mL suspension of the 3 different C. neoformans preparation: Sabouraud (indicated in the figure as H99), cells from mice of regular size
(,20 mm) and giant cells (.20 mm). Since yeast cells from mice were treated with Streptomycin to reduce bacterial contamination (see Material and
Methods), a group of larvae was inoculated with 1% Streptomycin in PBS as a control. B) Distribution of cells recovered from caterpillars from the
different groups at different times of infection (days 0, 2 and 5).
doi:10.1371/journal.pone.0024485.g008
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inoculated as control. Haemocyte density was assessed by
obtaining the haemolymph from 10 larvae after different times
(2 h, 2 d, 5 d) after the administration of the inoculum as
described above. Haemolymph was immediately diluted 1:1 in
IPS buffer to prevent melanization. Density was assessed by
counting the haemocytes using a haemocytometer. All determi-
nations were performed on 4 independent experiments.
Galleria mellonella survival experiment with cells
recovered from infected mice
BALB/c mice were infected intratracheally with 50 mLo fa
2610
6/mL suspension in PBS of H99 cells grown overnight at
30uC in Sabouraud liquid medium as described in [64].
Autoclaved food, bedding and bottles were used to maintain the
animals. To minimize bacterial contamination, 1 g/L tetracycline
hydrochloride (Sigma Aldrich, St. Louis, MO, USA) was added to
the sterile drinking water. After 17 d, mice were euthanized using
CO2 and lungs were isolated. All the animal procedures used in
this study were approved by the Bioethical Committee for Animal
Welfare for the Instituto de Salud Carlos III (approved protocol
PA-39). Lung tissue was then homogenized in 10 mL of PBS
containing 1% Streptomycin and 1 mg/mL collagenase (Roche,
Mannheim, Germany). The use of Streptomycin avoided bacterial
contamination through the purification procedure, and for that
reason, was included in all the buffers and solutions used. The cell
suspension was incubated for 90 min at 37uC with occasional
vortex agitation, and washed several times with sterile distilled
water. Cell suspension was filtered through a 20 mm filter
(Millipore, Ireland) to separate cells with a cell body diameter
larger than 20 mm from smaller cells. In parallel, cells from H99
strain incubated in Sabouraud broth overnight at 30uC were also
examined as control. After determining the cell density of the
different cell fractions recovered from the mice, suspensions of
3610
5 cells/mL in PBS containing 1% Streptomycin were
prepared. An aliquot of these samples was plated on Sabouraud
agar plates to confirm the number the CFUs and the absence of
bacterial contamination of the samples.
Twenty larvae per group were injected as described previously.
A group of larvae was injected with PBS containing 1%
Streptomycin. Larvae were incubated at 37uC and the number
of dead caterpillars was scored daily. Differences in the survival of
the various groups were analyzed by the Kaplan-Meier method
using Graph Pad Prism 5 (La Jolla, CA, USA).
At selected time intervals after inoculation larvae were
homogenated and cryptococcal cells were recovered from every
group. Cells were suspended in India ink and several pictures were
taken. Total cell size, was measured using Adobe Photoshop and
graphs and statistic analysis were performed using Graph Pad
Prism 5 (La Jolla, CA, USA).
Statistical analysis
Graphs and statistical comparisons (Student’s t-test) were
performed using Graph Pad Prism 5 (La Jolla, CA, USA) and
Microsoft Excel.
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